FindTrial
Sign In

Validation of adjuvant chemotherapy for colorectal cancer in patients with renal dysfunction

Validation of adjuvant chemotherapy for colorectal cancer in patients with renal dysfunction - Validation of adjuvant chemotherapy for colorectal cancer in patients with renal dysfunction

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000047045
Enrollment
4327
Registered
2022-03-01
Start date
2022-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colon cancer

Interventions

None listed

Sponsors

Japanese Foundation for Multidisciplinary Treatment of Cancer
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All registered patients of clinical studies (JFMC33 / JFMC35 / JFMC37 / JFMC38 / JFMC41) conducted by JFMC in the past

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

MeasureTime frame
The following items will be evaluated for each severity of chronic renal failure. -overall survival -relapse-free survival -disease-free survival -Time-to-treatment-failure -Incidence of adverse events—

Countries

Japan

Contacts

Public ContactYukari/Masaru Kawamura/Mutoh

Japanese Foundation for Multidisciplinary Treatment of Cancer Data Management Section/Statistical Analysis Section

jfmc-dc@jfmc.or.jp0356277594

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026